NM_001009944.3:c.1119C>T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001009944.3(PKD1):c.1119C>T(p.Leu373Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.83 in 142,122 control chromosomes in the GnomAD database, including 48,164 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.83   (  48164   hom.,  cov: 30) 
 Exomes 𝑓:  0.78   (  295723   hom.  ) 
 Failed GnomAD Quality Control 
Consequence
 PKD1
NM_001009944.3 synonymous
NM_001009944.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -1.08  
Publications
12 publications found 
Genes affected
 PKD1  (HGNC:9008):  (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008] 
PKD1 Gene-Disease associations (from GenCC):
- autosomal dominant polycystic kidney diseaseInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- polycystic kidney disease 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- autosomal recessive polycystic kidney diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Caroli diseaseInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BP6
Variant 16-2117873-G-A is Benign according to our data. Variant chr16-2117873-G-A is described in ClinVar as Benign. ClinVar VariationId is 803174.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-1.08 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.94  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PKD1 | NM_001009944.3 | c.1119C>T | p.Leu373Leu | synonymous_variant | Exon 5 of 46 | ENST00000262304.9 | NP_001009944.3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.829  AC: 117786AN: 142016Hom.:  48111  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
117786
AN: 
142016
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.895  AC: 84660AN: 94572 AF XY:  0.894   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
84660
AN: 
94572
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF:  0.778  AC: 788669AN: 1014150Hom.:  295723  Cov.: 15 AF XY:  0.779  AC XY: 399855AN XY: 513052 show subpopulations 
GnomAD4 exome 
Data not reliable, filtered out with message: AS_VQSR
 AF: 
AC: 
788669
AN: 
1014150
Hom.: 
Cov.: 
15
 AF XY: 
AC XY: 
399855
AN XY: 
513052
show subpopulations 
African (AFR) 
 AF: 
AC: 
21374
AN: 
24004
American (AMR) 
 AF: 
AC: 
30591
AN: 
34792
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
16971
AN: 
22440
East Asian (EAS) 
 AF: 
AC: 
30799
AN: 
33690
South Asian (SAS) 
 AF: 
AC: 
60604
AN: 
71958
European-Finnish (FIN) 
 AF: 
AC: 
27115
AN: 
33930
Middle Eastern (MID) 
 AF: 
AC: 
2613
AN: 
3342
European-Non Finnish (NFE) 
 AF: 
AC: 
562781
AN: 
744750
Other (OTH) 
 AF: 
AC: 
35821
AN: 
45244
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.566 
Heterozygous variant carriers
 0 
 6785 
 13571 
 20356 
 27142 
 33927 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 12176 
 24352 
 36528 
 48704 
 60880 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.830  AC: 117892AN: 142122Hom.:  48164  Cov.: 30 AF XY:  0.833  AC XY: 57768AN XY: 69370 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
117892
AN: 
142122
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
57768
AN XY: 
69370
show subpopulations 
African (AFR) 
 AF: 
AC: 
34638
AN: 
38240
American (AMR) 
 AF: 
AC: 
12327
AN: 
14396
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2507
AN: 
3270
East Asian (EAS) 
 AF: 
AC: 
4667
AN: 
4848
South Asian (SAS) 
 AF: 
AC: 
3917
AN: 
4410
European-Finnish (FIN) 
 AF: 
AC: 
8214
AN: 
10092
Middle Eastern (MID) 
 AF: 
AC: 
229
AN: 
280
European-Non Finnish (NFE) 
 AF: 
AC: 
49211
AN: 
63808
Other (OTH) 
 AF: 
AC: 
1598
AN: 
1956
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.576 
Heterozygous variant carriers
 0 
 682 
 1364 
 2045 
 2727 
 3409 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 826 
 1652 
 2478 
 3304 
 4130 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Benign 
Submissions summary: Benign:7 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:3 
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Mar 27, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Polycystic kidney disease, adult type    Benign:3 
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 03, 2018
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.